190 related articles for article (PubMed ID: 34697327)
1. Risk factors of recurrence and distant metastasis in primary cutaneous melanoma in Taiwan.
Lee TL; Liao YH; Liau JY; Sheen YS
Sci Rep; 2021 Oct; 11(1):21012. PubMed ID: 34697327
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing locoregional recurrence and distant metastasis in Asian patients with cutaneous melanoma after surgery: A retrospective analysis in a tertiary hospital in Taiwan.
Chu PY; Chen YF; Li CY; Yang JS; King YA; Chiu YJ; Ma H
J Chin Med Assoc; 2021 Sep; 84(9):870-876. PubMed ID: 34282077
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and prognosis of Asian patients with acral lentiginous melanoma who have nodal nevi in their sentinel lymph node biopsy specimen.
Kim HJ; Seo JW; Roh MS; Lee JH; Song KH
J Am Acad Dermatol; 2018 Oct; 79(4):706-713. PubMed ID: 29673774
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological characteristics and prognosis in significantly thick acral lentiginous melanoma in Taiwan.
Lee TL; Lin MH; Liao YH; Liau JY; Sheen YS
J Formos Med Assoc; 2022 Nov; 121(11):2338-2344. PubMed ID: 34961669
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of acral lentiginous histologic type in T1 melanoma.
Mejbel HA; Torres-Cabala CA; Milton DR; Ivan D; Feldmeyer L; Namikawa K; Nagarajan P; Tetzlaff MT; Curry JL; Ross MI; Hwu WJ; Prieto VG; Aung PP
Mod Pathol; 2021 Mar; 34(3):572-583. PubMed ID: 32759976
[TBL] [Abstract][Full Text] [Related]
6. National Comprehensive Analysis of Characteristics of Acral Lentiginous Melanoma.
Huayllani MT; Restrepo DJ; Boczar D; Avila FR; Bagaria SP; Spaulding AC; Rinker BD; Forte AJ
Anticancer Res; 2020 Jun; 40(6):3411-3415. PubMed ID: 32487638
[TBL] [Abstract][Full Text] [Related]
7. Acral lentiginous melanoma versus other melanoma: A single-center analysis in Japan.
Wada M; Ito T; Tsuji G; Nakahara T; Hagihara A; Furue M; Uchi H
J Dermatol; 2017 Aug; 44(8):932-938. PubMed ID: 28342269
[TBL] [Abstract][Full Text] [Related]
8. Acral Lentiginous Melanoma: Incidence and Survival in the United States, 2006-2015, an Analysis of the SEER Registry.
Huang K; Fan J; Misra S
J Surg Res; 2020 Jul; 251():329-339. PubMed ID: 32208196
[TBL] [Abstract][Full Text] [Related]
9. Acral Lentiginous Melanoma Is Associated with Certain Poor Prognostic Histopathological Factors but May Not be Correlated with Nodal Involvement, Recurrence, and a Worse Survival.
Tas F; Erturk K
Pathobiology; 2018; 85(4):227-231. PubMed ID: 29860247
[TBL] [Abstract][Full Text] [Related]
10. Does sentinel lymph node status have prognostic significance in patients with acral lentiginous melanoma?
Pavri SN; Han G; Khan S; Han D
J Surg Oncol; 2019 Jun; 119(8):1060-1069. PubMed ID: 30883783
[TBL] [Abstract][Full Text] [Related]
11. Malignant melanoma in Taiwan: a prognostic study of 181 cases.
Chang JW; Yeh KY; Wang CH; Yang TS; Chiang HF; Wei FC; Kuo TT; Yang CH
Melanoma Res; 2004 Dec; 14(6):537-41. PubMed ID: 15577327
[TBL] [Abstract][Full Text] [Related]
12. Acral lentiginous melanoma: histopathological prognostic features of 121 cases.
Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
Br J Dermatol; 2007 Aug; 157(2):311-8. PubMed ID: 17596173
[TBL] [Abstract][Full Text] [Related]
13. Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America.
Castaneda CA; Torres-Cabala C; Castillo M; Villegas V; Casavilca S; Cano L; Sanchez J; Dunstan J; Calderon G; De La Cruz M; Cotrina JM; Gomez HL; Galvez R; Abugattas J
Clin Transl Oncol; 2017 Dec; 19(12):1478-1488. PubMed ID: 28577153
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for Taiwanese patients with cutaneous melanoma undergoing sentinel lymph node biopsy.
Wu CE; Hsieh CH; Chang CJ; Yeh JT; Kuo TT; Yang CH; Lo YF; Lin KJ; Lin YC; Chang JW
J Formos Med Assoc; 2015 May; 114(5):415-21. PubMed ID: 23969039
[TBL] [Abstract][Full Text] [Related]
15. Acral lentiginous melanoma-Population, treatment, and survival using the NCDB from 2004 to 2015.
Bian SX; Hwang L; Hwang J; Ragab O; In GK; Peng D; Lin E
Pigment Cell Melanoma Res; 2021 Nov; 34(6):1049-1061. PubMed ID: 34273249
[TBL] [Abstract][Full Text] [Related]
16. A retrospective multicenter evaluation of cutaneous melanomas in Turkey.
Gamsizkan M; Yilmaz I; Buyukbabani N; Demirkesen C; Demiriz M; Cetin ED; Ince U; Akalin T; Demirkan NC; Lebe B; Erdem O; Gokoz O; Sakiz D; Demireli PT; Astarci HM; Adim SB; Zemheri IE; Acikalin A; Yaman B; Aydin O; Bassorgun CI
Asian Pac J Cancer Prev; 2014; 15(23):10451-6. PubMed ID: 25556491
[TBL] [Abstract][Full Text] [Related]
17. Analysis of recurrence patterns in acral versus nonacral melanoma: should histologic subtype influence treatment guidelines?
Gumaste PV; Fleming NH; Silva I; Shapiro RL; Berman RS; Zhong J; Osman I; Stein JA
J Natl Compr Canc Netw; 2014 Dec; 12(12):1706-12. PubMed ID: 25505211
[TBL] [Abstract][Full Text] [Related]
18. Caucasians with acral lentiginous melanoma have the same outcome as patients with stage- and limb-matched superficial spreading melanoma.
Susok L; Gambichler T
J Cancer Res Clin Oncol; 2022 Feb; 148(2):497-502. PubMed ID: 33856527
[TBL] [Abstract][Full Text] [Related]
19. Time-varying pattern of recurrence risk for localized melanoma in China.
Wen X; Li D; Zhao J; Li J; Yang T; Ding Y; Peng R; Zhu B; Huang F; Zhang X
World J Surg Oncol; 2020 Jan; 18(1):6. PubMed ID: 31901239
[TBL] [Abstract][Full Text] [Related]
20. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005.
Bradford PT; Goldstein AM; McMaster ML; Tucker MA
Arch Dermatol; 2009 Apr; 145(4):427-34. PubMed ID: 19380664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]